Literature DB >> 11682222

Simultaneous enantioseparation of cis-diltiazem hydrochloride and its metabolite cis-desacetyldiltiazem using high-performance liquid chromatography and capillary electrophoresis.

Bezhan Chankvetadze1, Irma Kartozia, Gottfried Blaschke.   

Abstract

Two alternative methods were developed using high-performance liquid chromatography (HPLC) and capillary electrophoresis (CE) for a simultaneous enantioselective determination of Ca(2+) blocking chiral drug cis-diltiazem hydrochloride (DLT) and its degradation product and metabolite cis-desacetyldiltiazem (Desac-DLT). The methods were compared from the viewpoint of analytical performance. The identification of HPLC peaks were performed using off-line electrospray ionization mass spectrometry. In addition, CE method was evaluated for quantitative determination of minor enantiomeric impurities in pharmacologically active (+)-cis-DLT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11682222     DOI: 10.1016/s0731-7085(01)00553-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Optimized separation of beta-blockers with multiple chiral centers using capillary electrochromatography-mass spectrometry.

Authors:  William Bragg; Dean Norton; Shahab A Shamsi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-01       Impact factor: 3.205

2.  Validated gradient stability indicating HPLC method for determining Diltiazem Hydrochloride and related substances in bulk drug and novel tablet formulation.

Authors:  Vivekanand A Chatpalliwar; Pawan K Porwal; Neeraj Upmanyu
Journal:  J Pharm Anal       Date:  2012-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.